ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.016 AUD -5.88%
Market Cap: AU$32.6m

ImpediMed Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ImpediMed Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Inventory
AU$2.3m
CAGR 3-Years
25%
CAGR 5-Years
24%
CAGR 10-Years
4%
Somnomed Ltd
ASX:SOM
Inventory
AU$7.6m
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
17%
Cochlear Ltd
ASX:COH
Inventory
AU$566.1m
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
14%
Optiscan Imaging Ltd
ASX:OIL
Inventory
AU$1.8m
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
51%
Austco Healthcare Ltd
ASX:AHC
Inventory
AU$11.2m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Inventory
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ImpediMed Ltd
Glance View

Market Cap
32.6m AUD
Industry
Health Care

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 73 full-time employees. The company went IPO on 2007-10-24. The firm develops various medical products that use bioimpedance spectroscopy (BIS) to measure and monitor fluid status and tissue composition. Its product includes SOZO Digital Health Platform. The company is a non-invasive BIS device delivers a snapshot of fluid status and tissue composition in approximately 30 seconds. The Company’s SOZO Applications offer clinicians deeper insights into a patient’s health. SOZO Applications include various software applications, such as L-Dex Analysis for Lymphedema, Body Composition Analysis, Segmental Analysis and HF-Dex Analysis for Heart Failure. The Company’s research devices include SFB7 and ImpediVET. SFB7 single channel, tetrapolar BIS device, which measures fluid status and tissue composition for clinical and research applications.

IPD Intrinsic Value
LOCKED
Unlock

See Also

What is ImpediMed Ltd's Inventory?
Inventory
2.3m AUD

Based on the financial report for Dec 31, 2025, ImpediMed Ltd's Inventory amounts to 2.3m AUD.

What is ImpediMed Ltd's Inventory growth rate?
Inventory CAGR 10Y
4%

Over the last year, the Inventory growth was 151%. The average annual Inventory growth rates for ImpediMed Ltd have been 25% over the past three years , 24% over the past five years , and 4% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett